LFVN Quote, Financials, Valuation and Earnings

Bridgford Foods has a net margin of 5.94% compared to Lifevantage's net margin of -7.62%. Lifevantage's return on equity of 31.7% beat Bridgford Foods's return on equity of -5.83%.

Lifevantage has a consensus price target of $18.00, signalling upside risk potential of 42.41%. On the other hand Bridgford Foods has an analysts' consensus of -- which suggests that it could fall by --. Given that Lifevantage has higher upside potential than Bridgford Foods, analysts believe Lifevantage is more attractive than Bridgford Foods.

Lifevantage has a beta of 0.432, which suggesting that the stock is 56.848% less volatile than S&P 500. In comparison Bridgford Foods has a beta of -0.237, suggesting its less volatile than the S&P 500 by 123.705%.

Lifevantage has a quarterly dividend of $0.05 per share corresponding to a yield of 1.31%. Bridgford Foods offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifevantage pays 236.3% of its earnings as a dividend. Bridgford Foods pays out -- of its earnings as a dividend.

Lifevantage quarterly revenues are $58.4M, which are larger than Bridgford Foods quarterly revenues of $50.6M. Lifevantage's net income of $3.5M is higher than Bridgford Foods's net income of -$3.9M. Notably, Lifevantage's price-to-earnings ratio is 18.32x while Bridgford Foods's PE ratio is 62.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifevantage is 0.74x versus 0.30x for Bridgford Foods. Usually stocks with elevated PS ratios are considered overvalued.

Better Choice has a net margin of 5.94% compared to Lifevantage's net margin of 13.42%. Lifevantage's return on equity of 31.7% beat Better Choice's return on equity of -199.75%.

Lifevantage has a consensus price target of $18.00, signalling upside risk potential of 42.41%. On the other hand Better Choice has an analysts' consensus of $10.00 which suggests that it could grow by 1770.91%. Given that Better Choice has higher upside potential than Lifevantage, analysts believe Better Choice is more attractive than Lifevantage.

Lifevantage has a beta of 0.432, which suggesting that the stock is 56.848% less volatile than S&P 500. In comparison Better Choice has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.427%.

Lifevantage has a quarterly dividend of $0.05 per share corresponding to a yield of 1.31%. Better Choice offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifevantage pays 236.3% of its earnings as a dividend. Better Choice pays out -- of its earnings as a dividend.

Lifevantage quarterly revenues are $58.4M, which are larger than Better Choice quarterly revenues of $11.4M. Lifevantage's net income of $3.5M is higher than Better Choice's net income of $1.5M. Notably, Lifevantage's price-to-earnings ratio is 18.32x while Better Choice's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifevantage is 0.74x versus 0.02x for Better Choice. Usually stocks with elevated PS ratios are considered overvalued.

Healthy Choice Wellness has a net margin of 5.94% compared to Lifevantage's net margin of -3.52%. Lifevantage's return on equity of 31.7% beat Healthy Choice Wellness's return on equity of -43.51%.

Lifevantage has a consensus price target of $18.00, signalling upside risk potential of 42.41%. On the other hand Healthy Choice Wellness has an analysts' consensus of $2.00 which suggests that it could grow by 344.25%. Given that Healthy Choice Wellness has higher upside potential than Lifevantage, analysts believe Healthy Choice Wellness is more attractive than Lifevantage.

Lifevantage has a beta of 0.432, which suggesting that the stock is 56.848% less volatile than S&P 500. In comparison Healthy Choice Wellness has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lifevantage has a quarterly dividend of $0.05 per share corresponding to a yield of 1.31%. Healthy Choice Wellness offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifevantage pays 236.3% of its earnings as a dividend. Healthy Choice Wellness pays out -- of its earnings as a dividend.

Lifevantage quarterly revenues are $58.4M, which are larger than Healthy Choice Wellness quarterly revenues of $20.3M. Lifevantage's net income of $3.5M is higher than Healthy Choice Wellness's net income of -$712.4K. Notably, Lifevantage's price-to-earnings ratio is 18.32x while Healthy Choice Wellness's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifevantage is 0.74x versus 0.06x for Healthy Choice Wellness. Usually stocks with elevated PS ratios are considered overvalued.

Laird Superfood has a net margin of 5.94% compared to Lifevantage's net margin of -1.34%. Lifevantage's return on equity of 31.7% beat Laird Superfood's return on equity of -7.4%.

Lifevantage has a consensus price target of $18.00, signalling upside risk potential of 42.41%. On the other hand Laird Superfood has an analysts' consensus of $12.67 which suggests that it could grow by 81.99%. Given that Laird Superfood has higher upside potential than Lifevantage, analysts believe Laird Superfood is more attractive than Lifevantage.

Lifevantage has a beta of 0.432, which suggesting that the stock is 56.848% less volatile than S&P 500. In comparison Laird Superfood has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lifevantage has a quarterly dividend of $0.05 per share corresponding to a yield of 1.31%. Laird Superfood offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifevantage pays 236.3% of its earnings as a dividend. Laird Superfood pays out -- of its earnings as a dividend.

Lifevantage quarterly revenues are $58.4M, which are larger than Laird Superfood quarterly revenues of $11.7M. Lifevantage's net income of $3.5M is higher than Laird Superfood's net income of -$156.2K. Notably, Lifevantage's price-to-earnings ratio is 18.32x while Laird Superfood's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifevantage is 0.74x versus 1.57x for Laird Superfood. Usually stocks with elevated PS ratios are considered overvalued.